InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-37.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Mattessich Antony C., Chairman & CEO. Insider active across 3 companies, notably OCULAR THERAPEUTIX, INC. Aggregated, 11 reports have been published. Split: 3 buys · 2 sells. Total volume traded: €268k. Activity tracked since 20 August 2021. The latest transaction was disclosed on 20 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
15,000 sharesCommon StockSEC:0001193125-26-271165:0
10,500 shares0Common StockSEC:0000950170-24-076715:0
180,400 shares0Common StockSEC:0001104659-24-011195:0
18,338 shares@ US$4.9537.0% of flowCommon StockSEC:0001104659-24-010231:0
6,500 shares@ US$3.8110.0% of flowCommon StockSEC:0001104659-23-098019:0
Ideal exit: 26 May 2024 (T+270)
19,669 shares@ US$4.2434.2% of flowCommon StockSEC:0001104659-23-014678:0
176,300 shares0Common StockSEC:0001104659-23-009410:0
186,750 shares0Common StockSEC:0001104659-22-012918:0
186,750 shares0Common StockSEC:0001104659-22-012918
5,000 shares@ US$9.890.0021% mcap100.0% of flowCommon StockSEC:0001104659-21-108777:0
Ideal exit: 17 May 2022 (T+270)
5,000 shares@ US$9.89100.0% of flowCommon StockSEC:0001104659-21-108777
Ideal exit: 17 May 2022 (T+270)
11 of 11 declarations
About Mattessich Antony C.
Antony C. Mattessich is the President and CEO of OCULAR THERAPEUTIX, INC. He leads the company in developing innovative treatments for eye diseases.
